Provexis plc

PXS

GB00B0923P27

Food Processing

Market Closed - London S.E. Other stock markets 11:35:24 2024-05-23 am EDT			5-day change	1st Jan Change
0.625 ^GBX	+4.17%		+4.17%	-3.85%

Apr. 03	Quiz sales fall, names new CEO; Byotrol eyes AIM exit	AN
2023	Provexis plc Reports Earnings Results for the Half Year Ended September 30, 2023	CI

Provexis plc Provides Revenues Guidance for the Year Ended 31 March 2019

July 31, 2019 at 02:00 am EDT

Provexis plc provided revenues guidance for the year ended 31 March 2019. The Company expects to report revenues for the year ended 31 March 2019 of £322,000, a 37% year on year increase (2018: £236,000).

Latest news about Provexis plc

Quiz sales fall, names new CEO; Byotrol eyes AIM exit	Apr. 03	AN
Provexis plc Reports Earnings Results for the Half Year Ended September 30, 2023	Dec. 29	CI
EARNINGS: Ebiquity swings to profit; SDX Energy swings to loss	23-09-29	AN
Provexis plc Reports Earnings Results for the Full Year Ended March 31, 2023	23-09-29	CI
Provexis notes regulatory filing for Fruitflow in China	23-08-30	AN
Provexis' Local Partner Files for New Health Function Claim for Foods in China; Rises 12%	23-08-30	MT
Redx confirms Jounce deal lapses, Tirupati seals deal	23-04-03	AN
EARNINGS SUMMARY: Provexis and Unicorn Mineral post chunkier losses	22-12-30	AN
Provexis plc Reports Earnings Results for the Half Year Ended September 30, 2022	22-12-30	CI
UK shareholder meetings calendar - next 7 days	22-10-26	AN
UK shareholder meetings calendar - next 7 days	22-10-25	AN
UK shareholder meetings calendar - next 7 days	22-10-24	AN
UK shareholder meetings calendar - next 7 days	22-10-21	AN
UK shareholder meetings calendar - next 7 days	22-10-20	AN
Provexis plc Announces Directorate Change	22-10-14	CI
Earnings Flash (PXS.L) PROVEXIS Reports FY22 Loss GBX-0.01	22-09-30	MT
Earnings Flash (PXS.L) PROVEXIS Posts FY22 Revenue GBP426,168	22-09-30	MT
Provexis plc Reports Earnings Results for the Full Year Ended March 31, 2022	22-09-30	CI
Provexis plc Auditor Raises 'Going Concern' Doubt	22-09-29	CI
Provexis, Enters into Alliance Agreement for Fruitflow® with Dsm Nutritional Products	22-06-22	CI
Provexis plc Announces the Filing of New Patent Application	22-06-22	CI
Earnings Flash (PXS.L) PROVEXIS Reports Fiscal H1 Revenue GBP211,195	21-12-31	MT
Earnings Flash (PXS.L) PROVEXIS Posts Fiscal H1 Loss GBX-0.01	21-12-31	MT
Provexis plc Reports Earnings Results for the Half Year Ended September 30, 2021	21-12-31	CI
Provexis plc Announces Agreement Between Provexis and By-Health for Supply of Fruitflow and Support in R&D	21-11-04	CI

Chart Provexis plc

Duration

Period

More charts

Company Profile

Provexis plc is engaged in developing, licensing and selling the proprietary, scientifically proven Fruitflow heart-health functional food ingredient. Fruitflow is a natural extract from tomatoes, which has been shown in human trials to reduce the propensity for aberrant blood clotting, typically associated with cardiovascular disease, which can lead to heart attack and stroke. The extract is available in two formats, a syrup and a spray-dried powder and can be included in a range of food, beverage, and dietary supplement formats. Fruitflow is a highly concentrated form of bioactives that is lycopene-free and contains over 30 known anti-platelet compounds. The syrup and powder versions of Fruitflow are GRAS in the United States. The Company also offers Fruitflow+ Omega-3, a dietary supplement product. The Company sells its Fruitflow+ Omega-3 dietary supplement product direct to consumers and serves its Chinese cross-border e-commerce distributor for this product in China.

Sector

Food Processing

Calendar

2024-09-25 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Special Foods & Wellbeing Products

	1st Jan change	Capi.
PROVEXIS PLC	-3.85%	17.28M
ZHEJIANG NHU COMPANY LTD.	+15.09%	8.35B
BELLRING BRANDS, INC.	+3.37%	7.62B
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	+1.45%	6.01B
THE SIMPLY GOOD FOODS COMPANY	-6.26%	3.75B
BYHEALTH CO., LTD	-9.86%	3.7B
XIAMEN KINGDOMWAY GROUP COMPANY	-6.55%	1.34B
HERBALIFE LTD.	-28.83%	1.13B
SIRIO PHARMA CO., LTD.	+14.31%	992M
USANA HEALTH SCIENCES, INC.	-10.78%	925M